(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDCLUERX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MEDCLUERX

ST13

US500000087227366

Class

42

Filing

87227366

Registration

5308238

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

02/22/2026

Trademark type

Combined

Nice classes

42

Filing date

11/04/2016

Registration date

10/10/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/16/2024

Last transaction

02/22/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/12/2017

First use in commerce

01/12/2017

Drawing code

3

Owner type

99

Owner location

Evanston, IL, US

Examiner

JOHNSON, DONALD

Law office

L40

Current location

TMEG LAW OFFICE 104

Mark description

The mark consists of the words "MEDCLUE" and a superscript "RX" and three circles located below the superscript "RX".

Holders and representatives

Holders

N. H. (pessoa física)
N. H. (pessoa física)

Representatives

Rosanne Yang InfoLawGroup LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing scientific analysis and informational reports in the field of geneticsgenomicsDNA testinggenetic testinggenetic screeninggenotypingphenotypingmolecular analyticspharmacogenomicsassessing risks associated with certain diseases; reporting services based upon the results of laboratory testing in the field of geneticsgenomicsDNA testinggenetic testinggenetic screeninggenotypingphenotypingmolecular analyticspharmacogenomicsassessing risks associated with certain diseases

Publications

History of USPTO decisions and trademark events.

37 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/20/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/20/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/20/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/20/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/20/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/16/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/16/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/16/2024

E815

TEAS SECTION 8 & 15 RECEIVED

08/29/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/10/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/22/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/22/2019

CORV

REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED

05/10/2018

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/02/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/30/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

10/10/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/08/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/07/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/24/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/22/2017

IUAF

USE AMENDMENT FILED

07/31/2017

EISU

TEAS STATEMENT OF USE RECEIVED

07/31/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/02/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/07/2017

PUBO

PUBLISHED FOR OPPOSITION

03/07/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/15/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/09/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/07/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/06/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/06/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/14/2016

GNRT

NON-FINAL ACTION E-MAILED

12/14/2016

CNRT

NON-FINAL ACTION WRITTEN

12/14/2016

DOCK

ASSIGNED TO EXAMINER

12/08/2016

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/10/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/09/2016

NWAP

NEW APPLICATION ENTERED

11/08/2016

Continuous trademark protection

Get notified about every new filing that threatens MEDCLUERX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.